-
Anemia-Related Survival of Patients with Myelofibrosis: A Retrospective Real-World Study
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Adjuvant Chemotherapy for Soft Tissue Sarcoma Using Linked NETSARC+ (French Registry) and SNDS (French National Health Data System) Real World Data: The Deepsarc Study
Mar 10, 2025, 14:00 PM -
Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America
Mar 10, 2025, 14:00 PM -
Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)
Mar 10, 2025, 14:00 PM -
Drivers of High ICERs in SMC Appraisals
Mar 10, 2025, 14:00 PM -
Hypophosphatasia (HPP) Patient & Caregiver Disease Burden, Quality of Life & Treatment Experience: A Mixed Methods Study Concept
Mar 10, 2025, 14:00 PM -
Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM -
US Stakeholder Perspectives on Accumulators, Maximizers, and Alternative Funding Programs: Implications for Patient Affordability and Outcomes Research
Mar 10, 2025, 14:00 PM -
Developing a Budget Impact R Shiney Application to Assess the Financial Implications of Implementing Organized Cancer Screening Programs in Countries with Limited Resources: Breast Cancer as an Example
Mar 10, 2025, 14:00 PM -
A Retrospective Medical Expenditure Panel Survey Database Study Assessing Factors Associated with Health Status Among United States Adults with Asthma
Mar 10, 2025, 14:00 PM -
A Budget Impact Analysis of Introducing OPSYNVI for the Treatment of Adult Patients Diagnosed With Pulmonary Arterial Hypertension
Mar 10, 2025, 14:00 PM -
Demonstration of a Population-Level Biomarker Testing Economic Evaluation Tool for Oncology Interventions
Mar 10, 2025, 14:00 PM